Free Trial
NASDAQ:APM

Aptorum Group (APM) Stock Price, News & Analysis

Aptorum Group logo
$1.45
+0.02 (+1.40%)
(As of 11/1/2024 ET)

About Aptorum Group Stock (NASDAQ:APM)

Key Stats

Today's Range
$1.36
$1.46
50-Day Range
$1.42
$3.13
52-Week Range
$1.35
$17.49
Volume
7,983 shs
Average Volume
734,443 shs
Market Capitalization
$7.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.

Aptorum Group Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
29th Percentile Overall Score

APM MarketRank™: 

Aptorum Group scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Book Value per Share Ratio

    Aptorum Group has a P/B Ratio of 0.49. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.12% of the float of Aptorum Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptorum Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptorum Group has recently increased by 22.73%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aptorum Group does not currently pay a dividend.

  • Dividend Growth

    Aptorum Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.12% of the float of Aptorum Group has been sold short.
  • Short Interest Ratio / Days to Cover

    Aptorum Group has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aptorum Group has recently increased by 22.73%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Aptorum Group has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Aptorum Group this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for APM on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Aptorum Group to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aptorum Group insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    63.99% of the stock of Aptorum Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 3.80% of the stock of Aptorum Group is held by institutions.

  • Read more about Aptorum Group's insider trading history.
Receive APM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptorum Group and its competitors with MarketBeat's FREE daily newsletter.

APM Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Aptorum Group Limited (APM)
Aptorum Group Limited Class A
See More Headlines

APM Stock Analysis - Frequently Asked Questions

Aptorum Group's stock was trading at $2.45 at the beginning of the year. Since then, APM shares have decreased by 40.7% and is now trading at $1.4530.
View the best growth stocks for 2024 here
.

Shares of Aptorum Group reverse split before market open on Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of APM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptorum Group investors own include Pfizer (PFE), Meta Platforms (META), Adobe (ADBE), Cisco Systems (CSCO), Walt Disney (DIS), Gilead Sciences (GILD) and Amgen (AMGN).

Company Calendar

Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:APM
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$430,000.00
Book Value
$2.97 per share

Miscellaneous

Free Float
1,866,000
Market Cap
$7.53 million
Optionable
Not Optionable
Beta
1.43
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NASDAQ:APM) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners